345 related articles for article (PubMed ID: 25316847)
1. Vaccine-derived polioviruses.
Burns CC; Diop OM; Sutter RW; Kew OM
J Infect Dis; 2014 Nov; 210 Suppl 1():S283-93. PubMed ID: 25316847
[TBL] [Abstract][Full Text] [Related]
2. Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use.
Duintjer Tebbens RJ; Hampton LM; Thompson KM
BMC Infect Dis; 2018 Apr; 18(1):165. PubMed ID: 29631539
[TBL] [Abstract][Full Text] [Related]
3. Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus.
Riquet FB; Blanchard C; Jegouic S; Balanant J; Guillot S; Vibet MA; Rakoto-Andrianarivelo M; Delpeyroux F
J Virol; 2008 Sep; 82(17):8927-32. PubMed ID: 18579607
[TBL] [Abstract][Full Text] [Related]
4. Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).
Duintjer Tebbens RJ; Pallansch MA; Kim JH; Burns CC; Kew OM; Oberste MS; Diop OM; Wassilak SG; Cochi SL; Thompson KM
Risk Anal; 2013 Apr; 33(4):680-702. PubMed ID: 23470192
[TBL] [Abstract][Full Text] [Related]
5. Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021.
Martin J; Burns CC; Jorba J; Shulman LM; Macadam A; Klapsa D; Majumdar M; Bullows J; Frolov A; Mate R; Bujaki E; Castro CJ; Bullard K; Konz J; Hawes K; Gauld J; Blake IM; Mercer LD; Kurji F; Voorman A; Diop OM; Oberste MS; Modlin J; Macklin G; Eisenhawer M; Bandyopadhyay AS; Zipursky S
MMWR Morb Mortal Wkly Rep; 2022 Jun; 71(24):786-790. PubMed ID: 35709073
[TBL] [Abstract][Full Text] [Related]
6. Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining Serotypes.
Thompson KM; Duintjer Tebbens RJ
J Infect Dis; 2017 Jul; 216(suppl_1):S168-S175. PubMed ID: 28838198
[TBL] [Abstract][Full Text] [Related]
7. Evolution and circulation of type-2 vaccine-derived polioviruses in Nad Ali district of Southern Afghanistan during June 2009-February 2011.
Sharif S; Abbasi BH; Khurshid A; Alam MM; Shaukat S; Angez M; Rana MS; Zaidi SS
PLoS One; 2014; 9(2):e88442. PubMed ID: 24558390
[TBL] [Abstract][Full Text] [Related]
8. Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993.
Yang CF; Naguib T; Yang SJ; Nasr E; Jorba J; Ahmed N; Campagnoli R; van der Avoort H; Shimizu H; Yoneyama T; Miyamura T; Pallansch M; Kew O
J Virol; 2003 Aug; 77(15):8366-77. PubMed ID: 12857906
[TBL] [Abstract][Full Text] [Related]
9. Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient.
Yang CF; Chen HY; Jorba J; Sun HC; Yang SJ; Lee HC; Huang YC; Lin TY; Chen PJ; Shimizu H; Nishimura Y; Utama A; Pallansch M; Miyamura T; Kew O; Yang JY
J Virol; 2005 Oct; 79(20):12623-34. PubMed ID: 16188964
[TBL] [Abstract][Full Text] [Related]
10. Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence.
Yeh MT; Bujaki E; Dolan PT; Smith M; Wahid R; Konz J; Weiner AJ; Bandyopadhyay AS; Van Damme P; De Coster I; Revets H; Macadam A; Andino R
Cell Host Microbe; 2020 May; 27(5):736-751.e8. PubMed ID: 32330425
[TBL] [Abstract][Full Text] [Related]
11. Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame.
Pons-Salort M; Burns CC; Lyons H; Blake IM; Jafari H; Oberste MS; Kew OM; Grassly NC
PLoS Pathog; 2016 Jul; 12(7):e1005728. PubMed ID: 27384947
[TBL] [Abstract][Full Text] [Related]
12. Emergence and localized circulation of a vaccine-derived poliovirus in an isolated mountain community in Guangxi, China.
Yan D; Li L; Zhu S; Zhang Y; An J; Wang D; Wen N; Jorba J; Liu W; Zhong G; Huang L; Kew O; Liang X; Xu W
J Clin Microbiol; 2010 Sep; 48(9):3274-80. PubMed ID: 20631095
[TBL] [Abstract][Full Text] [Related]
13. Asymptomatic immunodeficiency-associated vaccine-derived poliovirus infections in two UK children.
Singanayagam A; Klapsa D; Burton-Fanning S; Hand J; Wilton T; Stephens L; Mate R; Shillitoe B; Celma C; Slatter M; Flood T; Gopal R; Martin J; Zambon M
Nat Commun; 2023 Jun; 14(1):3413. PubMed ID: 37296153
[TBL] [Abstract][Full Text] [Related]
14. Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties.
Yakovenko ML; Cherkasova EA; Rezapkin GV; Ivanova OE; Ivanov AP; Eremeeva TP; Baykova OY; Chumakov KM; Agol VI
J Virol; 2006 Mar; 80(6):2641-53. PubMed ID: 16501074
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the future.
Korotkova EA; Park R; Cherkasova EA; Lipskaya GY; Chumakov KM; Feldman EV; Kew OM; Agol VI
J Virol; 2003 Dec; 77(23):12460-5. PubMed ID: 14610170
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 Infection Among Women in Iran Exposed vs Unexposed to Children Who Received Attenuated Poliovirus Used in Oral Polio Vaccine.
Habibzadeh F; Sajadi MM; Chumakov K; Yadollahie M; Kottilil S; Simi A; Stafford K; Saeidimehr S; Rafiei M; Gallo RC
JAMA Netw Open; 2021 Nov; 4(11):e2135044. PubMed ID: 34817583
[TBL] [Abstract][Full Text] [Related]
17. Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?
Devaux CA; Pontarotti P; Levasseur A; Colson P; Raoult D
Front Public Health; 2023; 11():1284337. PubMed ID: 38259741
[TBL] [Abstract][Full Text] [Related]
18. Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global Cessation.
Tebbens RJD; Hampton LM; Wassilak SGF; Pallansch MA; Cochi SL; Thompson KM
J Vaccines Vaccin; 2016 Oct; 7(5):. PubMed ID: 28690915
[TBL] [Abstract][Full Text] [Related]
19. Direct detection of Sabin poliovirus vaccine strains in stool specimens of first-dose vaccinees by a sensitive reverse transcription-PCR method.
Buonagurio DA; Coleman JW; Patibandla SA; Prabhakar BS; Tatem JM
J Clin Microbiol; 1999 Feb; 37(2):283-9. PubMed ID: 9889205
[TBL] [Abstract][Full Text] [Related]
20. Vaccine-associated paralytic poliomyelitis in oral polio vaccine recipients: disproportionality analysis using VAERS and systematic review.
Suares JE; Khan S; Aadrika A; Poojari PG; Rashid M; Thunga G
Expert Opin Drug Saf; 2024 May; ():1-13. PubMed ID: 38813942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
